Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug–Drug Interactions and Co-medication Regimens

Details 詳細情報について

• CRID

  1363951793594627968

• DOI

  10.1208/s12248-016-0009-9

• ISSN

  15507416

• Web Site

  http://link.springer.com/content/pdf/10.1208/s12248-016-0009-9.pdf

  http://link.springer.com/article/10.1208/s12248-016-0009-9/fulltext.html

• Data Source

  • Crossref